EUVIMEDEUVIMED entdecken
Crossref

Epidemiology of KPC-producing Enterobacterales isolated from 2019 to 2023 in France

Lamia Rouabah, Sarah Ronsin, Axelle Vasseur, Inès Rezzoug iD, Sandrine Bernabeu, Aurélien Birer, Cécile Emeraud, Thierry Naas iD, Rémy A Bonnin, Laurent Dortet iD, Agnès B Jousset

Journal of Antimicrobial Chemotherapy · 2026

DOI: 10.1093/jac/dkag273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Lamia Rouabah und 10 weiteren Autor:innen. Beteiligte Einrichtung: Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France. Hauptthemen laut MEDLINE: beta-Lactamases, Bacterial Proteins, Enterobacteriaceae, Enterobacteriaceae Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: SEPSIS Comprehensive Center, French National Research Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The global spread of Klebsiella pneumoniae carbapenemase (KPC)-type carbapenemases has historically been driven by clonal group CG258, but increasing clonal diversification has recently been reported. We aimed to provide a comprehensive phenotypic and genomic characterization of KPC-producing Enterobacterales referred to French National Center (NRC) for Antimicrobial Resistance between 2019 and 2023. Materials and methods A total of 419 KPC-producing Enterobacterales were referred to the French NRC for Antimicrobial Resistance. Antimicrobial susceptibility testing was performed by broth microdilution. Whole-genome sequencing was conducted for 404 isolates. AMR gene detection, MLST and SNP-based phylogeny were used to analyse resistance mechanisms, clonal structure and outbreak dynamics.

Results

KPC-producing Enterobacterales accounted for ∼2% of all carbapenemase-producing Enterobacterales. The K. pneumoniae species complex represented 86% (363/419) of isolates. KPC-3 predominated (328/419, 78%), followed by KPC-2 (87/419, 21%). Additional carbapenemases were detected in 11 isolates. Ceftazidime-avibactam, imipenem-relebactam and meropenem-vaborbactam showed high in vitro activity (97.8%, 95.8% and 97.9% susceptibility, respectively). MLST of 353 K. pneumoniae genomes identified 45 sequence types (STs); ST307 predominated (39.4%) and was associated with a major outbreak in northern France. ST147 (8.8%) and ST512 (7.6%) were also prevalent. Fifteen isolates from ST11, ST39, ST101, and ST395 had high virulence score of 4 (iuc-positive).

Conclusions

KPC-producing K. pneumoniae referred to the French NRC show marked clonal diversification. The emergence of resistant isolates and convergent resistance-virulence profiles underscore the need for sustained genomic surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesBacterial ProteinsEnterobacteriaceaeEnterobacteriaceae InfectionsFranceMicrobial Sensitivity TestsAnti-Bacterial AgentsHumansWhole Genome SequencingPhylogenyKlebsiella pneumoniaeMultilocus Sequence TypingDrug Resistance, Multiple, Bacterial

Substanzen

beta-LactamasesBacterial ProteinscarbapenemaseAnti-Bacterial Agents

Autor:innen und Institutionen

  • Assistance Publique Hôpitaux de Paris, Groupe Hospitalier Universitaire Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France.
  • Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases » (IMVA-HB/IDMIT/UMRS1184), Fontenay-aux-Roses & Le Kremlin-Bicêtre, France.
  • Department of Bacteriology-Hygiene, Bicêtre Hospital, Assistance Publique - Hôpitaux de Paris, Le Kremlin-Bicêtre, France.
  • French Associated National Reference Center for Antibiotic Resistance, Le Kremlin-Bicêtre, France.
  • SEPSIS Comprehensive Center - IHU SEPSIS, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
  • French Associated National Reference Center for Antibiotic Resistance, Clermont-Ferrand, France.

ORCID-Profile: Inès Rezzoug, Thierry Naas, Laurent Dortet

Förderung

  • SEPSIS Comprehensive Center
  • French National Research Agency

Zitieren

APA

Rouabah, L., Ronsin, S., Vasseur, A., Rezzoug, I., Bernabeu, S., Birer, A., Emeraud, C., Naas, T., Bonnin, R. A., Dortet, L., & Jousset, A. B. (2026). Epidemiology of KPC-producing Enterobacterales isolated from 2019 to 2023 in France. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkag273

Vancouver

Rouabah L, Ronsin S, Vasseur A, Rezzoug I, Bernabeu S, Birer A, et al. Epidemiology of KPC-producing Enterobacterales isolated from 2019 to 2023 in France. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkag273

BibTeX
@article{Rouabah2026,
  author = {Rouabah, Lamia and Ronsin, Sarah and Vasseur, Axelle and Rezzoug, Inès and Bernabeu, Sandrine and Birer, Aurélien and Emeraud, Cécile and Naas, Thierry and Bonnin, Rémy A and Dortet, Laurent and Jousset, Agnès B},
  title = {Epidemiology of KPC-producing Enterobacterales isolated from 2019 to 2023 in France},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  doi = {10.1093/jac/dkag273}
}
Kostenlos starten →